Nvidia (NVDA)-backed SandboxAQ said Wednesday it released data that it hopes will facilitate the creation of new computational methods for the identification of new drugs.
The dataset of about 5.2 million computationally folded three-dimensional protein-drug molecule co-structures allows the creation of better models to predict structures and potencies, SandboxAQ said.
The artificial intelligence startup said the dataset includes experimental measurements of a drug's so-called potency, which is connected to how strongly the drug binds to a target protein related to a disease of interest.
Price: 143.61, Change: -0.51, Percent Change: -0.35
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.